Suppr超能文献

[继发性骨质疏松症。糖皮质激素诱导的骨质疏松症患者的治疗疗效证据]

[Secondary osteoporosis. Evidence of treatment efficacy in patients with glucocorticoid-induced osteoporosis].

作者信息

Sato Shinji

机构信息

Keio University School of Medicine, Department of Internal Medicine.

出版信息

Clin Calcium. 2007 Apr;17(4):600-5.

Abstract

Recently a number of therapies have been reported on the treatment efficacy for glucocorticoid-induced osteoporosis (GIOP) . Especially, bisphosphonates have been proven to have both prevention and treatment of GIOP by large-scale randomized double-blinded placebo controlled studies and recommended the use of them as a first line therapy by treatment guideline in many countries. On the other hand, activated vitamin D(3) analogues also have been reported the effectiveness of GIOP although the effect is lower than bisphosphonates. Vitamin K(2) analogues suggested to have the efficacy in treatment of GIOP in Japan. This article reviews the evidence of treatment efficacy of current treatment especially bisphosphonates in patients with GIOP.

摘要

最近,已有多项关于糖皮质激素性骨质疏松症(GIOP)治疗效果的疗法被报道。特别是,双膦酸盐已通过大规模随机双盲安慰剂对照研究被证明对GIOP具有预防和治疗作用,并在许多国家被治疗指南推荐作为一线治疗药物使用。另一方面,活性维生素D(3)类似物也被报道对GIOP有效,尽管其效果低于双膦酸盐。维生素K(2)类似物在日本被认为对GIOP治疗有效。本文综述了目前治疗方法尤其是双膦酸盐对GIOP患者治疗效果的证据。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验